Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Discriminating Between Latent and Active Tuberculosis: The Role of Interleukin-2 As Biomarker Publisher Pubmed



Mamishi S1, 2 ; Pourakbari B1 ; Marjani M3 ; Bahador A4 ; Mahmoudi S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatric Infectious Disease Research Center, Tehran University of Medical Science, Tehran, Iran
  2. 2. Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Department of Microbiology, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Infection Published:2015


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Novel T-Cell Assays for the Discrimination of Active and Latent Tuberculosis Infection: The Diagnostic Value of Ppe Family, Molecular Diagnosis and Therapy (2015)
2. Improving T-Cell Assays for Diagnosis of Latent Tb Infection: Confirmation of the Potential Role of Testing Interleukin-2 Release in Iranian Patients, Allergologia et Immunopathologia (2016)
3. Diagnostic Accuracy of Interferon (Ifn)-Γ Inducible Protein 10 (Ip-10) As a Biomarker for the Discrimination of Active and Latent Tuberculosis, Molecular Biology Reports (2019)
4. Interferon Gamma Release Assay in Response to Pe35/Ppe68 Proteins: A Promising Diagnostic Method for Diagnosis of Latent Tuberculosis, European Cytokine Network (2017)
5. Evaluation of Treatment Response in Active Tuberculosis Using Quantiferon-Tb Gold Plus, European Cytokine Network (2020)
6. Differential Gene Expression of Asun, Nemf, Ptprc and Dhx29: Candidate Biomarkers for the Diagnosis of Active and Latent Tuberculosis, Infectious Disorders - Drug Targets (2021)
7. Diagnostic Accuracy of Monocyte Chemotactic Protein (Mcp)-2 As Biomarker in Response to Pe35/Ppe68 Proteins: A Promising Diagnostic Method for the Discrimination of Active and Latent Tuberculosis, Protein and Peptide Letters (2019)
8. Comparison of the Quantiferon-Tb Gold Plus and Quantiferon-Tb Gold In-Tube Interferon-Γ Release Assays: A Systematic Review and Meta-Analysis, Advances in Medical Sciences (2019)
Experts (# of related papers)
View all Related Experts
Shima Mahmoudi (9)
Setareh Mamishi Khanlagh (9)
Other Related Docs
9. Evaluation of the Quantiferon®-Tb Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital, Infectious Disorders - Drug Targets (2019)